Earnings reports loom: Social media chatter around P3 Health Partners centers on its upcoming financial results, with the ticker appearing in multiple lists of companies set to report earnings on August 10.
Debt restructuring noted: Recent posts also reference the firm's prior term loan adjustments, highlighting a shift to cash-and-PIK interest payments that add to principal balances while requiring some cash outflows.
Market focus shifts: Overall sentiment remains neutral amid the anticipation, as traders weigh operational updates against broader sector pressures without strong bullish or bearish consensus emerging.
Note: This discussion summary was generated from an AI condensation of post data.
P3 Health Partners Revenue
P3 Health Partners had revenues of $386.4M in Q1 2026. This is an increase of 3.53% from the same period in the prior year.
You can track PIII financials on Quiver Quantitative's PIII stock page.
You can access data on PIII stock through the Quiver Quantitative API.
P3 Health Partners Hedge Fund Activity
We have seen 7 institutional investors add shares of P3 Health Partners stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. removed 137,406 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $423,210
- NINE MASTS CAPITAL LTD removed 17,964 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $194,011
- ABUNDANCE WEALTH COUNSELORS added 16,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $172,800
- HRT FINANCIAL LP added 15,092 shares (+inf%) to their portfolio in Q1 2026, for an estimated $46,483
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 13,371 shares (+inf%) to their portfolio in Q1 2026, for an estimated $41,182
- LIDO ADVISORS, LLC removed 10,748 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $116,078
- DIVERSIFIED TRUST CO removed 6,876 shares (-33.8%) from their portfolio in Q2 2026, for an estimated $74,260
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
P3 Health Partners Price Targets
Multiple analysts have issued price targets for $PIII recently. We have seen 2 analysts offer price targets for $PIII in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $14.0 on 05/22/2026
- Ben Haynor from Lake Street set a target price of $14.0 on 05/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
